4.7 Article

Association of estimated sleep duration and naps with mortality and cardiovascular events: a study of 116 632 people from 21 countries

期刊

EUROPEAN HEART JOURNAL
卷 40, 期 20, 页码 1620-1629

出版社

OXFORD UNIV PRESS
DOI: 10.1093/eurheartj/ehy695

关键词

Sleep duration; Naps; Cardiovascular diseases; Mortality

资金

  1. Heart and Stroke Foundation of Ontario
  2. Population Health Research Institute
  3. Canadian Institutes of Health Research (CIHR)
  4. CIHR's Strategy for Patient Oriented Research (SPOR), through Ontario SPOR Support Unit
  5. Ontario Ministry of Health and Long-Term Care
  6. AstraZeneca (Canada)
  7. SanofiAventis (France)
  8. SanofiAventis (Canada)
  9. Boehringer Ingelheim (Germany)
  10. Boehringer Ingelheim (Canada)
  11. Servier
  12. GlaxoSmithKline
  13. Novartis
  14. King Pharma
  15. Argentina: Fundacion ECLA (Estudios Clinicos Latino America)
  16. Bangladesh: Independent University, Bangladesh
  17. Brazil: Unilever Health Institute, Brazil
  18. Canada: Public Health Agency of Canada
  19. Canada: Champlain Cardiovascular Disease Prevention Network
  20. Chile: Universidad de la Frontera
  21. China: National Center for Cardiovascular Diseases
  22. Colombia: Colciencias [6566-04-18062]
  23. India: Indian Council of Medical Research
  24. Malaysia: Ministry of Science, Technology and Innovation of Malaysia [100-IRDC/BIOTEK 16/6/21 (13/2007), 07-05-IFN-BPH 010]
  25. Malaysia: Ministry of Higher Education of Malaysia [600-RMI/LRGS/5/3 (2/2011)]
  26. Malaysia: Universiti Teknologi MARA
  27. Malaysia: Universiti Kebangsaan Malaysia [UKM-Hejim-Komuniti-15-2010]
  28. United Nations Relief and Works Agency for Palestine Refugees in the Near East (UNRWA)
  29. International Development Research Centre (IDRC), Canada
  30. Philippines: Philippine Council for Health Research & Development (PCHRD)
  31. Poland: Polish Ministry of Science and Higher Education [290/W-PURE/2008/0]
  32. Poland: Wroclaw Medical University
  33. Saudi Arabia: Saudi Heart Association
  34. Saudi Arabia: King Saud University, Riyadh, Saudi Arabia [RG-1436-013]
  35. South Africa: The North-West University, SANPAD (SA and Netherlands Programme for Alternative Development)
  36. South Africa: National Research Foundation
  37. South Africa: Medical Research Council of SA
  38. South Africa: SA Sugar Association (SASA)
  39. South Africa: Faculty of Community and Health Sciences (UWC)
  40. Swedish Heart and Lung Foundation
  41. Swedish Research Council
  42. Swedish Council for Health, Working Life and Welfare
  43. King Gustaf V's and Queen Victoria Freemasons Foundation
  44. AFA Insurance
  45. Turkey: Metabolic Syndrome Society
  46. Turkey: AstraZeneca, Turkey
  47. Turkey: Sanofi Aventis, Turkey
  48. United Arab Emirates: Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences
  49. United Arab Emirates: Dubai Health Authority, Dubai UAE
  50. China Scholarship Council (CSC)
  51. Bangladesh: Mitra and Associates

向作者/读者索取更多资源

Aims To investigate the association of estimated total daily sleep duration and daytime nap duration with deaths and major cardiovascular events. Methods and results We estimated the durations of total daily sleep and daytime naps based on the amount of time in bed and self-reported napping time and examined the associations between them and the composite outcome of deaths and major cardiovascular events in 116 632 participants from seven regions. After a median follow-up of 7.8 years, we recorded 4381 deaths and 4365 major cardiovascular events. It showed both shorter (<= 6 h/day) and longer (>8 h/day) estimated total sleep durations were associated with an increased risk of the composite outcome when adjusted for age and sex. After adjustment for demographic characteristics, lifestyle behaviours and health status, a J-shaped association was observed. Compared with sleeping 6-8 h/day, those who slept <= 6 h/day had a nonsignificant trend for increased risk of the composite outcome [hazard ratio (HR), 1.09; 95% confidence interval, 0.99-1.20]. As estimated sleep duration increased, we also noticed a significant trend for a greater risk of the composite outcome [HR of 1.05 (0.99-1.12), 1.17 (1.09-1.25), and 1.41 (1.30-1.53) for 8-9 h/day, 9-10 h/day, and >10 h/day, P-trend < 0.0001, respectively]. The results were similar for each of all-cause mortality and major cardiovascular events. Daytime nap duration was associated with an increased risk of the composite events in those with over 6 h of nocturnal sleep duration, but not in shorter nocturnal sleepers (<= 6 h). Conclusion Estimated total sleep duration of 6-8 h per day is associated with the lowest risk of deaths and major cardiovascular events. Daytime napping is associated with increased risks of major cardiovascular events and deaths in those with >6 h of nighttime sleep but not in those sleeping <= 6 h/night.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据